Back
ArrowMark Financial Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
35
BANX
ArrowMark Financial
Last Price:
$20.10
Seasonality Move:
0.83%
Sell
27
CRSP
CRISPR Therapeutics AG
Last Price:
$37.78
Seasonality Move:
21.79%
Sell
35
ArrowMark Financial (BANX)
is a Sell
Is ArrowMark Financial a Buy, Sell or Hold?
-
The current ArrowMark Financial [BANX] share price is $20.24. The Score for BANX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
BANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.77. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BANX Stock Price Chart
What is ArrowMark Financial's stock price today?
-
The ArrowMark Financial share price today is $20.24The current trend is relatively stagnant and BANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
BANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 51.5 | Buy |
| Chaikin Money Flow: | 11809 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.3 - 21.24) | Sell |
| Bollinger Bands (100): | (20.19 - 21.41) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.36 | Buy |
| Relative Strength Index (14 RSI): | 49.46 | Sell |
| Chaikin Money Flow: | 99115 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.98 - 41.22) | Buy |
| Bollinger Bands (100): | (37.58 - 47.38) | Sell |
BANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.3 | Buy |
| 20-day SMA: | 20.05 | Buy |
| 50-day SMA: | 20.68 | Sell |
| 200-day SMA: | 20.4 | Sell |
| 8-day EMA: | 19.69 | Buy |
| 20-day EMA: | 19.95 | Buy |
| 50-day EMA: | 20.43 | Sell |
| 200-day EMA: | 20.25 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.63 | Buy |
| 20-day SMA: | 36.55 | Buy |
| 50-day SMA: | 40.9 | Sell |
| 200-day SMA: | 46.21 | Sell |
| 8-day EMA: | 36.89 | Buy |
| 20-day EMA: | 32.04 | Buy |
| 50-day EMA: | 20.78 | Buy |
| 200-day EMA: | 6.95 | Buy |
ArrowMark Financial Earnings Growth & BANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.91 per share.
ArrowMark Financial Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||